EWL ETF Analysis: Switzerland | NYSE
Focused Region | NYSE, USA | Market Cap: 2.332m USD | 12M Return: 14.6% | US4642867497 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 23.6M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The iShares MSCI Switzerland ETF (EWL) seeks to track the MSCI Switzerland Index, a free float-adjusted, market capitalization-weighted benchmark covering large- and mid-cap Swiss equities. The fund invests at least 80% of its assets in the indexs component securities or in instruments with substantially identical economic characteristics.
As a non-diversified ETF, EWL offers targeted exposure to the Swiss equity market, which is concentrated in sectors such as pharmaceuticals, financial services, and consumer staples-areas dominated by a handful of large multinational companies headquartered in Switzerland.
- Swiss franc appreciation drags USD investor returns
- Novartis and Roche earnings dominate healthcare-heavy index weighting
- SNB rate policy shifts pressure UBS and Swiss bank holdings
As of September 27, 2026, the stock is trading at USD 60.66 with a total of 305,122 shares traded. Over the past week, the price has changed by +1.03%, over one month by -6.24%, over three months by -3.41% and over the past year by +14.62%.
Current recommended Stop Loss: 59.30 (which is 2.2% or 1.9 ATR below the current price).
Switzerland has no consensus analysts rating.